API
< Back to situations

[PERSON]

Hwang Sang-yeon

Featured in 1 tracked story · first seen

Situations

[QUIET] [BUSINESS] [KR]

Hanmi Pharm Epe obesity drug development and launch

2 clusters · 4 sources · last updated

Latest: Hanmi Pharm launches Epe, a domestic GLP-1 obesity drug

Hanmi Pharm has progressed through the clinical and commercial stages of Epe, a domestic GLP-1 class obesity treatment developed using local technology. During Phase 3 clinical trials in South Korea, the clinical trial